Cargando…
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913489/ https://www.ncbi.nlm.nih.gov/pubmed/36765955 http://dx.doi.org/10.3390/cancers15030586 |
| _version_ | 1784885440181960704 |
|---|---|
| author | Zheng, Haosheng Long, Guojie Zheng, Yuzhen Yang, Xingping Cai, Weijie He, Shiyun Qin, Xianyu Liao, Hongying |
| author_facet | Zheng, Haosheng Long, Guojie Zheng, Yuzhen Yang, Xingping Cai, Weijie He, Shiyun Qin, Xianyu Liao, Hongying |
| author_sort | Zheng, Haosheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9913489 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99134892023-02-11 Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 Zheng, Haosheng Long, Guojie Zheng, Yuzhen Yang, Xingping Cai, Weijie He, Shiyun Qin, Xianyu Liao, Hongying Cancers (Basel) Correction MDPI 2023-01-18 /pmc/articles/PMC9913489/ /pubmed/36765955 http://dx.doi.org/10.3390/cancers15030586 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Zheng, Haosheng Long, Guojie Zheng, Yuzhen Yang, Xingping Cai, Weijie He, Shiyun Qin, Xianyu Liao, Hongying Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 |
| title | Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 |
| title_full | Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 |
| title_fullStr | Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 |
| title_full_unstemmed | Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 |
| title_short | Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344 |
| title_sort | correction: zheng et al. glycolysis-related slc2a1 is a potential pan-cancer biomarker for prognosis and immunotherapy. cancers 2022, 14, 5344 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913489/ https://www.ncbi.nlm.nih.gov/pubmed/36765955 http://dx.doi.org/10.3390/cancers15030586 |
| work_keys_str_mv | AT zhenghaosheng correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT longguojie correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT zhengyuzhen correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT yangxingping correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT caiweijie correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT heshiyun correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT qinxianyu correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 AT liaohongying correctionzhengetalglycolysisrelatedslc2a1isapotentialpancancerbiomarkerforprognosisandimmunotherapycancers2022145344 |